![Mani Mohindru](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mani Mohindru
Directeur Général chez
CARDIFF ONCOLOGY, INC.
Fortune : - $ au 31/05/2026
Profil
Mani Mohindru is the founder of Immtox LLC, founded in 2012.
Dr. Mohindru is also the founder of Roshon Therapeutics, Inc...
Dr. Mohindru is President, Chief Executive Officer & Director at Cardiff Oncology, Inc. since 2026 and Independent Director at CytomX Therapeutics, Inc. since 2020.
Former positions include Chief Executive Officer at CereXis, Inc. from 2019 to 2020; Chief Executive Officer & Director at Novasenta, Inc. from 2021 to 2024; Managing Director at Capstone Investments; Director at SAB Sciences, Inc. from 2020 to 2021; Research Analyst at Credit Suisse Securities (USA) LLC (Broker); Chief Strategy Officer at Curis, Inc. from 2016 to 2017; Research Analyst at UBS Securities LLC; Chief Financial & Strategy Officer at CARA Therapeutics, Inc. from 2017 to 2019; Analyst at ThinkEquity LLC; Partner at Axon Healthcare Ltd. from 2009 to 2011.
Education includes a doctorate from Northwestern University conferred in 2003 and undergraduate and graduate degrees from All India Institute of Medical Sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mani Mohindru
| Sociétés | Poste | Début |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/12/2020 |
| CARDIFF ONCOLOGY, INC. | Directeur Général | 27/01/2026 |
Anciens postes connus de Mani Mohindru
| Sociétés | Poste | Fin |
|---|---|---|
Novasenta, Inc.
 Novasenta, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for cancer | Directeur Général | 01/03/2024 |
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Directeur/Membre du Conseil | 01/05/2021 |
CereXis, Inc. | Directeur Général | 01/10/2020 |
| CARA THERAPEUTICS, INC. | Directeur Financier/CFO | 20/12/2019 |
| CURIS, INC. | Investor Relations Contact | 01/03/2016 |
Formation de Mani Mohindru
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Capstone Investments
 Capstone Investments Investment Banks/BrokersFinance Provides brokerage services | Finance |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
All India Institute of Medical Sciences
 All India Institute of Medical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ThinkEquity LLC
 ThinkEquity LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Immtox LLC | |
Axon Healthcare Ltd. | |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
CereXis, Inc. | |
Novasenta, Inc.
Novasenta, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for cancer | Commercial Services |
